Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Beijing Tong Ren Tang Chinese Medicine Company Limited BJTRF

Set alert

Price alert · BJTRF

All alert types
0.65 USD 0.00 0.00%

At close · Oct 30

0.6484 Day range 0.6484
0.6484 52-week range 0.6484
YTD
0.00%
1 year
0.00%
Open
0.6484
Prev close
0.6484
Mkt cap
542.78M
Vol
400
Avg vol
0
EPS
0.08
P/E
8.11
More statistics
Low
0.6484
High
0.6484

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jun 1, 2021Dividend: 0.0309
  • Jun 14, 2022Dividend: 0.0357
  • Jun 15, 2022Dividend: 0.28
  • Oct 6, 2022Dividend: 0.0318
  • Oct 7, 2022Dividend: 0.25
  • May 10, 2023Dividend: 0.0421
  • Jun 4, 2024Dividend: 0.33
  • Jun 12, 2024Dividend: 0.0422433
  • Jun 14, 2024Dividend: 0.0422
  • May 30, 2025Dividend: 0.045108
  • Jun 5, 2025Dividend: 0.045
  • Jun 9, 2025Dividend: 0.0446
  • Jun 12, 2026Dividend: 0.0510536
  • Jun 16, 2026Dividend: 0.051
Signals (8)
NameDateAgo
SMA: BullishOct 21, 20242 years ago
MACD: Buy SignalJul 8, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
MACD: Sell SignalApr 1, 20242 years ago
RSI: OversoldApr 1, 20242 years ago
RSI: OverboughtMar 25, 20242 years ago

Financial health

Altman Z-Score

12.26 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

S-5 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 4

Valuation

P/E 10.7×
FY 2016: 23.1×FY 2017: 20.1×FY 2018: 16.9×FY 2019: 17.3×FY 2020: 17.8×FY 2021: 15.9×FY 2022: 15.1×FY 2023: 17.9×FY 2024: 1.1×FY 2025: 10.7×
FY 2016 5y median 15.1× FY 2025
P/S 2.8×
FY 2016: 8.9×FY 2017: 7.7×FY 2018: 6.5×FY 2019: 6.8×FY 2020: 7.4×FY 2021: 6.2×FY 2022: 5.6×FY 2023: 6.4×FY 2024: 0.3×FY 2025: 2.8×
FY 2016 5y median 5.6× FY 2025
P/B 1.0×
FY 2016: 4.6×FY 2017: 3.9×FY 2018: 3.4×FY 2019: 3.6×FY 2020: 3.2×FY 2021: 2.8×FY 2022: 2.7×FY 2023: 2.5×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 2.5× FY 2025
P/FCF 5.1×
FY 2016: 22.1×FY 2017: 21.6×FY 2018: 17.8×FY 2019: 16.7×FY 2020: 75.6×FY 2021: 12.9×FY 2022: 18.8×FY 2023: 33.6×FY 2024: -16.2×FY 2025: 5.1×
FY 2016 5y median 12.9× FY 2025
EV/EBITDA 3.7×
FY 2016: 16.2×FY 2017: 14.3×FY 2018: 12.3×FY 2019: 11.3×FY 2020: 10.9×FY 2021: 9.7×FY 2022: 8.9×FY 2023: 12.7×FY 2024: 3.6×FY 2025: 3.7×
FY 2016 5y median 8.9× FY 2025
EV/Sales 1.4×
FY 2016: 8.2×FY 2017: 7.1×FY 2018: 6.1×FY 2019: 6.1×FY 2020: 6.3×FY 2021: 5.3×FY 2022: 4.5×FY 2023: 5.8×FY 2024: 0.2×FY 2025: 1.4×
FY 2016 5y median 4.5× FY 2025
FCF Yield 19.6%
FY 2016: 4.5%FY 2017: 4.6%FY 2018: 5.6%FY 2019: 6.0%FY 2020: 1.3%FY 2021: 7.8%FY 2022: 5.3%FY 2023: 3.0%FY 2024: -6.2%FY 2025: 19.6%
FY 2016 5y median 5.3% FY 2025

Profitability

Gross Margin 61.2%
FY 2016: 71.9%FY 2017: 71.0%FY 2018: 70.0%FY 2019: 69.9%FY 2020: 72.5%FY 2021: 71.4%FY 2022: 66.5%FY 2023: 68.7%FY 2024: 8.5%FY 2025: 61.2%
FY 2016 5y median 66.5% FY 2025
Operating Margin 31.3%
FY 2016: 48.6%FY 2017: 47.3%FY 2018: 46.0%FY 2019: 45.3%FY 2020: 50.9%FY 2021: 49.5%FY 2022: 46.9%FY 2023: 40.9%FY 2024: 4.6%FY 2025: 31.3%
FY 2016 5y median 40.9% FY 2025
Net Margin 26.2%
FY 2016: 38.8%FY 2017: 38.7%FY 2018: 38.4%FY 2019: 38.8%FY 2020: 41.2%FY 2021: 39.1%FY 2022: 37.3%FY 2023: 276.7%FY 2024: 4.0%FY 2025: 26.2%
FY 2016 5y median 37.3% FY 2025
ROE 9.5%
FY 2016: 19.8%FY 2017: 19.7%FY 2018: 20.0%FY 2019: 20.9%FY 2020: 18.0%FY 2021: 17.8%FY 2022: 17.9%FY 2023: 109.2%FY 2024: 12.3%FY 2025: 9.5%
FY 2016 5y median 17.8% FY 2025
ROIC 8.7%
FY 2016: 19.6%FY 2017: 19.0%FY 2018: 19.2%FY 2019: 18.9%FY 2020: 17.0%FY 2021: 17.4%FY 2022: 17.6%FY 2023: 12.9%FY 2024: 7.1%FY 2025: 8.7%
FY 2016 5y median 12.9% FY 2025
ROA 8.5%
FY 2016: 17.8%FY 2017: 17.7%FY 2018: 18.3%FY 2019: 17.7%FY 2020: 15.8%FY 2021: 15.8%FY 2022: 15.2%FY 2023: 95.2%FY 2024: 11.0%FY 2025: 8.5%
FY 2016 5y median 15.2% FY 2025

Growth (YoY)

Revenue -87.9%
FY 2016: 11.8%FY 2017: 16.5%FY 2018: 19.8%FY 2019: -5.0%FY 2020: -8.5%FY 2021: 18.3%FY 2022: 11.1%FY 2023: -11.8%FY 2024: 720.9%FY 2025: -87.9%
FY 2016 FY 2025
Operating Income -17.5%
FY 2016: 16.6%FY 2017: 13.3%FY 2018: 16.5%FY 2019: -6.5%FY 2020: 2.8%FY 2021: 15.1%FY 2022: 5.3%FY 2023: -23.1%FY 2024: -8.1%FY 2025: -17.5%
FY 2016 FY 2025
EPS (diluted) -89.9%
FY 2016: 19.0%FY 2017: 16.0%FY 2018: 19.0%FY 2019: -2.9%FY 2020: -3.0%FY 2021: 12.3%FY 2022: 5.5%FY 2023: -15.6%FY 2024: 616.9%FY 2025: -89.9%
FY 2016 FY 2025
Free Cash Flow 417.5%
FY 2016: 30.4%FY 2017: 3.1%FY 2018: 21.5%FY 2019: 5.9%FY 2020: -78.0%FY 2021: 489.7%FY 2022: -31.3%FY 2023: -44.1%FY 2024: -189.8%FY 2025: 417.5%
FY 2016 FY 2025

Financial Health

Current Ratio 19.7×
FY 2016: 15.9×FY 2017: 15.6×FY 2018: 19.5×FY 2019: 8.6×FY 2020: 13.5×FY 2021: 15.4×FY 2022: 8.8×FY 2023: 11.7×FY 2024: 2.2×FY 2025: 19.7×
FY 2016 5y median 11.7× FY 2025
Quick Ratio 13.2×
FY 2016: 14.5×FY 2017: 14.0×FY 2018: 17.8×FY 2019: 7.6×FY 2020: 11.3×FY 2021: 13.4×FY 2022: 7.7×FY 2023: 8.6×FY 2024: 1.3×FY 2025: 13.2×
FY 2016 5y median 8.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -3.7×
FY 2016: -1.5×FY 2017: -1.2×FY 2018: -0.7×FY 2019: -1.2×FY 2020: -1.7×FY 2021: -1.8×FY 2022: -2.1×FY 2023: -1.2×FY 2024: -2.3×FY 2025: -3.7×
FY 2016 5y median -2.1× FY 2025
Interest Coverage 83.7×
FY 2016: 12263×FY 2017: 18710×FY 2018: 36629×FY 2019: 154×FY 2020: 156×FY 2021: 164×FY 2022: 174×FY 2023: 13.4×FY 2024: 88.6×FY 2025: 83.7×
FY 2016 5y median 88.6× FY 2025

Dividends

Dividend Yield 6.9%
FY 2016: 1.1%FY 2017: 1.4%FY 2018: 1.6%FY 2019: 8.2%FY 2020: 2.0%FY 2021: 2.1%FY 2022: 4.5%FY 2023: 2.8%FY 2024: 6.6%FY 2025: 6.9%
FY 2016 5y median 4.5% FY 2025
Payout Ratio 73.8%
FY 2016: 25.9%FY 2017: 27.3%FY 2018: 27.4%FY 2019: 143.0%FY 2020: 35.5%FY 2021: 33.1%FY 2022: 68.7%FY 2023: 6.5%FY 2024: 55.2%FY 2025: 73.8%
FY 2016 5y median 55.2% FY 2025

Annual · latest fiscal year ends 2025-12-31